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Background: Pulmonary rehabilitation (PR) is recommended for patients with respiratory
disease who feel limited by breathlessness. Poor attendance wastes finite resources,
increases waiting times and is probably associated with poorer clinical outcomes. We
investigated what factors, identifiable from routine hospital data, predict poor attendance
once enrolled in a pulmonary rehabilitation programme (PRP).
Methods: Retrospective case note study of 239 patients (60% male) of mean (S.D.) age of
66.6 (8.7) years, mean FEV1 39.6 (14.6)% predicted, who attended a 6 (short) or 18 (long)
week, 18 session, outpatient PRP. Attendance data was analysed using linear multiple
regression analysis with the log transformed odds ratio of attendance as the dependant
variable.
Results: Overall median attendance was 16 out of 18 sessions. Being a current smoker
(po0.05), attending a long PRP (po0.05), more previous hospital admissions (po0.01),
higher Medical Research Council (MRC) dyspnoea score (po0.01) or enduring a long
journey (po0.001) were independent risk factors for low attendance. Lower body mass
index (BMI) and distance from PR centre were of borderline importance (po0.1) but age,
gender, co-morbidity, respiratory diagnosis, FEV1 and St. Georges Respiratory Question-
naire Score at baseline did not predict later attendance (p40.2).
Conclusions: Attendance at PRPs is independently influenced by smoking status, the
degree of breathlessness, frequency of hospital admissions, length of the programme and
journey time.
& 2008 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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R. Sabit et al.820Introduction from clinical records: (1) age; (2) gender; (3) diagnosisPulmonary rehabilitation (PR) is integral in managing
patients with chronic respiratory disease and is recom-
mended in all guidelines, based on grade A evidence.1–3 In
addition to improving exercise capacity,4 reducing hospital
admissions, reducing symptoms of dyspnoea and improving
quality of life,5 patients who attend a pulmonary rehabilita-
tion programme (PRP) also exhibit better emotional function
and feel more in control of their illness.4 However, PR does
not benefit all to whom it is offered. Patients may
participate in programmes and not gain benefit but some
may either fail to attend when invited or drop out of the
programme without achieving an effective intervention.
A retrospective analysis in the UK showed that although
most patients benefited from PR, almost 23% of those who
attended their PRP, did not improve their health status or
exercise tolerance.6 Adequate attendance is important
in deriving benefit from PRPs and is included in the joint
ERS/ATS statement on PR.3 Poor attendance is likely to
contribute to suboptimal improvements or may be a marker
for more severe disease where gains may be less.
Patient attendance at PRPs has been variable with some
centres reporting a dropout rate as high as 30%.7 However,
few studies have investigated the causes of non-attendance.
Young et al.8 found that social isolation, lack of support,
continued smoking and non-compliance with other health-
care activities were significantly associated with patients
declining entry into a PRP. However, this study only included
91 patients and did not examine what factors were
associated with poor attendance after they were enrolled
and had agreed to participate. Identifying factors associated
with poor attendance should allow specific interventions to
improve attendance, which should optimise outcomes and
target finite resources most efficiently.
The aim of this study is to investigate what physiological
or environmental factors, routinely available at baseline,
could predict later attendance once enrolled at a PRP.
Methods
Patients
This was a retrospective analysis of consecutive case notes of
patients who were already enrolled in an outpatient PRP.
A total of 243 patients (146 males) with a mean (S.D.) age of
66.6 years (78.7 years) who attended at least one session our
PRP between July 2000 and February 2004 were included.
Patients were referred by primary and secondary care
physicians; they were predominantly white from a range of
social classes around a UK city. Two hundred and four patients
had a diagnosis of chronic obstructive pulmonary disease
(COPD), whilst 28 patients had a mixed asthma/COPD picture
and 11 patients had chronic asthma. Eligibility criteria for our
patients have been published previously.5 All data collection
was approved by the local research ethics committee.
Data collection
The following predictors (pre-PRP data) of attendance
were regarded as routine data in any PRP and were recorded(COPD or other); (4) body mass index (BMI); (5)% predicted
forced expiratory volume in 1 s (FEV1); (6) Medical Research
Council (MRC) dyspnoea score; (7) St. George’s Respiratory
Questionnaire (SGRQ) total score; (8) number of COPD
exacerbations requiring hospital admission in the preceding
12 months; (9) self-reported smoking status; (10) pre-
sence of major co-morbidities, classified as cardiovascular,
neurological or musculoskeletal conditions; (11) distance
(in miles) between home and PRP (calculated using zip/post
codes); (12) average length of journey reported by patients
and (13) long (18 week) or short (6 week) PRP.
Rehabilitation programme
The programme has been described previously5 and includes
outpatient multidisciplinary input from occupational thera-
pists, physiotherapists, dietetics staff, physicians, specialist
respiratory nurses, social workers and a smoking cessation
counsellor. This PRP has a strong evidence base for a range
of beneficial clinical outcomes.5 As part of another
prospective study, patients were randomised to receive a
‘‘short’’ rehabilitation programme, consisting of three half-
day sessions per week for 6 weeks, or a ‘‘long’’ rehabilita-
tion programme, consisting of one half-day session per week
for 18 weeks.
Long and short PRPs had identical content and format,
each session lasting for approximately 2 h and including
educational activities, individualised exercise prescription,
and educational sessions addressing the psychological
aspects of chronic disability. Individual goal setting, dietary
intervention, physiotherapy and occupational therapy were
also included. The order of sessions was similar and there
was no provision made for additional sessions following non-
attendance.
Attendance
At screening interview by a respiratory physician, medica-
tion is optimised and only when deemed medically stable
(usually exacerbation free for at least 6 weeks) are patients
offered PR. The programme is described and patients were
strongly encouraged to attend every session and agreed in
advance to do so whenever possible. Patients are then sent
information regarding the PRP and what to expect prior to
commencement. Those who felt they could not attend
regularly were not enrolled. In addition, an administrator
assists with queries and can organise patient transport for
those requiring it. The dependant variable was the total
number of sessions attended. Subjects were also categorised
whether they had a 100% attendance record (complete
attendance) or not. In addition, patients were arbitrarily
categorized as ‘‘good attenders’’ if they attended 67% of
available session or ‘‘poor’’ if they attended less.
Statistical analysis
Data analysis was performed with the Statistical Package
for the Social Sciences, version 12.0 (SPSS Inc., Chicago,
IL, USA). Between-group comparisons (good versus poor
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Student’s t-test, Mann–Whitney and w2 tests.
Log transformation
Attendance data was positively skewed. To achieve a normal
distribution, we performed a log transformation of the odds
ratio of attendance, as shown by the equation:
Ln
ðattendancesþ 1Þ
absencesþ 1
 
.
Using this as our dependant variable, we calculated
Pearson’s correlations for our continuous independent
variables. For categorical variables, we compared atten-
dance across each category using one-way analysis of
variance. To assess the relationship between multiple
predictor variables and attendance, we developed a linear
regression model using forward stepwise procedures for all
13 independent variables.
Results
Whole group
One hundred and twenty-five (51%) patients were rando-
mised to participate in a short PRP, and 118 patients were
enrolled into a long PRP. Three patients from the short PRP
and one patient from the long PRP withdrew before the
programme commenced and were excluded from further
analysis. Patients in the short and long PRPs had similar
baseline demographics (details omitted).
Overall 52 patients (65% males) attended all 18 sessions;
they had a mean age 68.4 (8.2) years, mean Body Mass IndexTable 1 Comparison of baseline variables between eventual
attenders (o67% of total sessions attended).
Variable Good attenders (n ¼
Male (%) 56.1
Age (years) 67.079.0
BMI (kg/m2) 26.476.0
COPD diagnosis (%) 81.8
Current smokers (%) 17.7
FEV1 (% pred) 40.5714.8
MRC dyspnoea score 4 (3–5)
SGRQ total score 62.4715.8
Hospital admissions in last year 0.8271.34
Major co-morbidities (%) 48.3
Distance from PR centre (miles) 9.879.1
Length of journey (%)
o5min 2.2
6–15min 27.2
16–30min 44.4
430min 25.6
Short rehabilitation (%) 56.1
Data presented as mean7S.D. or percentages.
Median (interquartile range).(BMI) 27.3 (5.5) kg/m2, mean MRC score 3.5 (0.95), mean
FEV1 40.1 (16)% predicted and a mean of 0.66 (0.9) hospital
admissions in the preceding year. Seventeen percent
reported still smoking, 64% were on the short PRP and they
lived on average 8.8 (7.2) miles from the centre, with 50%
reported taking less than 30minute journey time.
Comparison between ‘‘good’’ and ‘‘poor’’-attenders
Table 1 compares the baseline characteristics of the ‘‘good’’
attenders and ‘‘poor’’ attenders.
Univariate analysis
A positive relationship with attendance was found with
higher BMI (po0.05), fewer hospital admissions in the last
year (po0.01), current (self-reported) non-smokers
(po0.01), a lower MRC dyspnoea score (po0.01) and a
shorter journey time to reach the PRP (po0.001).
Regression analysis
Table 2 shows the results of multiple regression analysis,
including only those variables associated with poor atten-
dance. The following were not significantly associated with
attendance and were excluded from the linear regression
model: age (p ¼ 0.53), gender (p ¼ 0.93), FEV1% (p ¼ 0.90),
co-morbidity (p ¼ 0.84), respiratory diagnosis (p ¼ 0.68),
baseline SGRQ (p ¼ 0.42) and BMI (p ¼ 0.27). Distance from
PRP centre showed a trend but was not a statistically
significant predictor in our model (p ¼ 0.08). Overall our
regression model still only accounts for 18% of the variance
in log ratio of attendance.good attenders (X67% of total sessions attended) and poor
180) Poor attenders (n ¼ 62) p-Value
69.4 0.15
67.678.3 0.64
24.775.8 0.06
87.9 0.44
56.5 o0.001
36.6714.2 0.07
5 (4–5) o0.001
65.5714.8 0.20
1.4271.43 0.004
61.3 0.08
9.077.0 0.55
0
8.1 o0.001
33.9
58.1
43.5 0.09
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Table 2 Results of multiple linear regression analysis for attendance using transformed data: Ln {(attendances+1)/
(absences+1)}.
Log attendance ratio Change statistics
Variables added at each stage Adjusted R2 R2 change F change d.f. Sig. F
1. Journey duration 0.062 0.062 15.309 1 o0.001
2. Journey duration and MRC score 0.117 0.055 0.13 2 o0.001
3. Journey duration and MRC score and smoker 0.141 0.024 2.425 3 o0.001
4. Journey duration and MRC score and smoker
and type of PRP
0.164 0.023 1.243 4 o0.001
5. Journey duration and MRC score and smoker
and type of PRP and number of hospital
admissions in the preceding year
0.176 0.012 1.343 5 o0.001
R. Sabit et al.822Discussion
In this retrospective analysis using routine and easily
accessible hospital data, we have demonstrated that
patients are less likely to attend a PRP if they are current
smokers, attend a long rehabilitation programme, previously
had frequent exacerbations requiring hospital admission,
have a high MRC dyspnoea score or endure a long journey.
Adherence is defined as ‘‘the extent to which a patient’s
behaviour coincides with medical advice’’ rather than
concordance where the patient and doctor both agree on
and negotiate conduct.9 Patients were strongly advised to
attend all 18 sessions so adherence is the more appropriate
term. Human behaviour is a complex phenomenon, which is
influenced by personal health beliefs, socio-cultural factors,
physical and psychological factors. In general, patient
non-adherence is one of the best documented but least
understood health-related behaviours.
Although several studies have investigated non-adherence
to medication in COPD, there is a paucity of data regarding
poor adherence to attending PRPs. Young et al.8 investigated
predictors of non-attendance in PR, but considered adher-
ence as a dichotomous variable, defining patients as being
‘‘non adherent’’ if they refused participation or began but
did not complete the whole programme. Most of their
patients labelled as ‘‘non adherent’’ actually refused any
participation in the programme. In our study, we have
considered attendance as a continuous variable to measure
the different degrees of patient attendance to the PRP.
When also using a dichotomous definition of ‘‘good’’ versus
‘‘poor’’ attenders, we accept 12 out of 18 sessions is
arbitrary but this is similar to others.6
Poor attendance at a PRP may parallel non-adherence
with medication or following other medical advice, such as
smoking cessation. In our study, patients who smoked had a
significantly worse attendance record than non-smokers.
A similar finding was reported by Young et al.8 and Cote
and Celli.10 Continued smoking has also been associated
with non adherence with therapy for hypertension.11 It is
plausible that patients who continue to smoke lack motiva-
tion skills, and are less willing to take a proactive approach
in managing their disease. Alternatively, they may feel
stigmatised or, for a highly addicted smoker, refraining from
smoking for 3 h, up to three times per week, may be abarrier too difficult to overcome. However, we do not feel
that smoking cessation is a pre-requisite for attendance at a
PRP as many smokers do benefit. Rather, such patients
should be offered extra support and encouragement to
participate in PR, whilst at the same time seeking
pharmacological help and smoking cessation counselling.
Although this analysis was retrospective, data was
collected prospectively as part of a randomised controlled
trial comparing long and short rehabilitation programmes. In
this study, attendance was found to be lower in the long,
less intensive rehabilitation programme. The reasons for this
may be related to the perceived lack of benefit, with similar
gains over a longer period resulting in a smaller incremental
gain over each week. In addition, patients attending PR over
18 weeks may lose motivation, fail to develop a group
identity or have more ‘‘opportunity’’ for more exacerba-
tions, indeed we found that more hospital admissions prior
to enrolment independently predicted later non-attendance
in our regression model.
We found patients with a high MRC dyspnoea score (4–5)
had a worse attendance record irrespective of length of PRP.
Such patients who are breathless at rest or on minimal
exertion may not be able to cope with the physiological
demands of the exercise training programme as well as the
difficulties of transport to and from home. Garrod et al.
found that severity of breathlessness or total SGRQ were not
significantly associated (p40.05) with dropping out of a PRP
but higher MRC score was associated with significantly
smaller health gains during PRP.6 For such symptomatic
patients, an inpatient or home PRP, or one with less
emphasis on exercise training may improve attendance.
However, Wedzicha et al.12 found no improvement in
exercise performance in severely dyspnoeic patients offered
PR at home. We did not offer a home PRP.
The fact that longer reported journey times were
independently associated with poor attendance is important
and the actual distance between patients’ homes and the PR
centre was of borderline statistical significance. Transport
difficulties are one of the biggest problems faced by PR
patients, many of whom are too unwell or unfit to drive.
Patients without personal or family transport may have to
rely on expensive taxis or hospital transport, which in our
experience results in longer journey times can be inefficient
and at times unreliable. A longer journey time is likely to
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disabled patients. This issue of transportation is exacer-
bated by lack of PR at many centres in the UK,13 forcing
patients to travel further (up to 65 miles in our study) to
other places. This continues to be a problem despite the
recommendations by the National Institute for Clinical
Excellence.1
Young et al.8 found that age, sex and physiological
parameters such as FEV1 did not predict attendance; we
confirm these findings.
Non-attendance at PRPs may have a number of unwanted
consequences. We know of no studies comparing medically
led versus ‘‘distance learning’’ or self-education style PRPs
but direct contact is likely to be important to encourage
training under direct supervision and provide direct,
personalised, support and feedback in teaching new
skills/illness understanding. Identifying barriers to attending
PRPs that we know will improve outcomes is crucial to
developing strategies to improve outcomes further. Rather
than excluding patients with risk factors for non-atten-
dance, we feel such patients should be identified and
offered extra support, perhaps even prior to commencing
the study. After proving that patients are more likely to
attend a short intensive PRP, we have now discontinued the
once weekly PRP.
We do not know if those that completed the PRP had a
better clinical response. Perhaps some people stopped
attending once a certain goal was reached. Larger numbers
would be needed to address this issue, preferably only using
a single type (intensive short) PRP. Moreover, the exact
primary clinical endpoint should be agreed on. The primary
endpoint in this study is attendance. We did not record the
reasons given by patients for non-attendance and in
particular did not differentiate between ‘‘avoidable’’ and
‘‘non-avoidable’’ reasons. Certain life events would make it
impossible to attend PRPs including intercurrent exacerba-
tions, admission to hospital or the ill health of a spouse,
whereas others such as transport delay or social commit-
ments should be modifiable. We do not know if those with
longer journey times relied more on hospital or public
transport although this is quite possible as they lived on
average only 1 mile further away. Type of transport should
be routinely documented when organising a PRP. Although
reasons for non-attendance may be difficult to document
accurately, are self-reported and mainly retrospective, they
may give further unique perspectives into patient behaviour.
Data regarding non-attendance due to intercurrent exacer-
bations would be very interesting but still retrospective and
open to interpretation and recall bias. It would serve no
practical purpose in generating prediction models at
baseline for people who have not actually had PR. We
concentrated on variables we thought would be clinically
important but also practical and easily collected before
starting PRP, to make our findings applicable in an every-day
setting. We did not focus in-depth on complex behaviour.
The issue of patient non-attendance is extremely multi-
faceted resulting from interactions between many variables,
some of which are impossible to measure and their interplay
is highly individual. However, we have identified five
significant predictors of poor attendance at PR that are
easily collected from routine hospital data sources. Offering
supportive interventions, targeted to at least these fivevariables will improve our understanding of this complex
health-related behaviour. The next steps are to see if better
attendance leads to better gains and ultimately perform
intervention studies to improve attendance. Only then can
we target limited resources not only to those who need
them most but also to those who will benefit most.
There were a number of limitations to our study. It was
originally designed to compare two different types of
rehabilitation programme. This is a post-hoc, retrospective
analysis on prospectively gathered data. We did not record
psychological parameters such as baseline anxiety and
depression scores or measures of perceived self-efficacy.
Many PRPs do not usually collect these and we wanted to see
what routine data at baseline could be used to generate
predictive models in all settings. We did not enter marital
status and social support that are readily available to most
PRPs and acknowledge that these should be included in
future models. Although we had zip-code data we did not
have reliable coding for the social economic groupings for
the patients. Such factors have been shown to influence
patient adherence in a number of clinical settings and could
well play a vital role in determining attendance to our PRP.
Our smoking status was not validated. We did not input
baseline measures of exercise capability into our model
because different assessment tools are used in different
centres and we wanted to make our findings as generic as
possible.
Conclusions
In this retrospective study, we have found that attendance
at PRPs is independently influenced by patient issues such as
smoking status, their degree of breathlessness and number
of hospital admissions but also logistical issues such as
length of the programme and journey time.
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